Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Core Insights - Whitehawk Therapeutics, Inc. is an oncology therapeutics company focused on advanced technologies to enhance ADC cancer treatments [1][2] - The company will participate in the BTIG Virtual Biotechnology Conference on July 29-30, 2025 [1] Company Overview - Whitehawk Therapeutics specializes in oncology therapeutics, utilizing advanced technologies to improve cancer treatment delivery [2] - The company has developed a three-asset ADC portfolio designed to address the limitations of first-generation treatments, aiming to significantly benefit patients with challenging cancers [2] - These assets are exclusively licensed from WuXi Biologics under a global commercialization agreement [2]